This NeoGenomics, Inc. (NEO) Stock Prediction Could Blow Your Mind
The Benchmark Company has recently reduced NeoGenomics, Inc. (NEO) stock to Hold rating, as announced on January 13, 2025, according to Finviz. Earlier, on December 10, 2024, Jefferies had initiated the stock to Buy, setting a price target of $22. Craig Hallum also resumed Buy rating with a price target of $26. Additionally, BTIG Research […]
Is NeoGenomics, Inc. (NEO) Stock About to Explode? Here’s What You Need to Know
The Benchmark Company has recently reduced NeoGenomics, Inc. (NEO) stock to Hold rating, as announced on January 13, 2025, according to Finviz. Earlier, on December 10, 2024, Jefferies had initiated the stock to Buy, setting a price target of $22. Craig Hallum also resumed Buy rating with a price target of $26. Additionally, BTIG Research […]
Is NeoGenomics, Inc. (NEO) Stock’s Valuation a Risky Bet?
The Benchmark Company has recently reduced NeoGenomics, Inc. (NEO) stock to Hold rating, as announced on January 13, 2025, according to Finviz. Earlier, on December 10, 2024, Jefferies had initiated the stock to Buy, setting a price target of $22. Craig Hallum also resumed Buy rating with a price target of $26. Additionally, BTIG Research […]
NEO Stock Fluctuations: The Real Story
The Benchmark Company has recently reduced NeoGenomics, Inc. (NEO) stock to Hold rating, as announced on January 13, 2025, according to Finviz. Earlier, on December 10, 2024, Jefferies had initiated the stock to Buy, setting a price target of $22. Craig Hallum also resumed Buy rating with a price target of $26. Additionally, BTIG Research […]
How Does NeoGenomics, Inc. (NEO) Stack Up Against Its Industry Peers?
The Benchmark Company has recently reduced NeoGenomics, Inc. (NEO) stock to Hold rating, as announced on January 13, 2025, according to Finviz. Earlier, on December 10, 2024, Jefferies had initiated the stock to Buy, setting a price target of $22. Craig Hallum also resumed Buy rating with a price target of $26. Additionally, BTIG Research […]
Why Did NeoGenomics, Inc. (NEO) Stock Plunge -10.43% Last Week?
Jefferies has recently initiated NeoGenomics, Inc. (NEO) stock to Buy rating, as announced on December 10, 2024, according to Finviz. Earlier, on May 1, 2024, Craig Hallum had resumed the stock to Buy, setting a price target of $26. BTIG Research also reiterated Buy rating with a price target of $21. Additionally, Stephens raised rating […]
Why Did NeoGenomics, Inc. (NEO) Stock See -13.63% Plunge in the Last 90 Days?
Craig Hallum has recently resumed NeoGenomics, Inc. (NEO) stock to Buy rating, as announced on May 1, 2024, according to Finviz. Earlier, on December 29, 2023, BTIG Research had reiterated the stock to Buy, setting a price target of $21 for NEO stock. Stephens also raised rating with a price target of $18. Additionally, Raymond […]
NeoGenomics, Inc. (NEO) Stock Price Reaches $13: What Factors Are Influencing This Level?
Craig Hallum has recently resumed NeoGenomics, Inc. (NEO) stock to Buy rating, as announced on May 1, 2024, according to Finviz. Earlier, on December 29, 2023, BTIG Research had reiterated the stock to Buy, setting a price target of $21 for NEO stock. Stephens also raised their rating with a price target of $18. Additionally, […]
NEO’s Recent Drop: What’s Causing the Decline?
Craig Hallum has recently resumed NeoGenomics, Inc. (NEO) stock to Buy rating, as announced on May 1, 2024, according to Finviz. Earlier, on December 29, 2023, BTIG Research had reiterated the stock to Buy, setting a price target of $21 for NEO stock. Stephens also raised their rating with a price target of $18. Additionally, […]
NeoGenomics, Inc. (NEO) Stock: More Resilient Than It Appears
Craig Hallum has recently resumed NeoGenomics, Inc. (NEO) stock to Buy rating, as announced on May 1, 2024, according to Finviz. Earlier, on December 29, 2023, BTIG Research had reiterated the stock to Buy, setting a price target of $21 for NEO stock. Stephens also raised their rating with a price target of $18. Additionally, […]
